Clinical Research Partnerships

Advancing health science through collaborative research partnerships with leading academic institutions, medical centers, and research organizations to develop evidence-based solutions for chronic disease prevention and treatment.

Research Collaboration Network

NexGenHealth.io partners with premier research institutions worldwide to conduct groundbreaking studies in preventive medicine, nutritional science, and digital health technologies. Our collaborative network includes top-tier universities, government research agencies, and private research organizations focused on addressing the chronic disease epidemic that affects 60% of Americans and drives 90% of healthcare costs.

Active Research Areas

Nutritional Interventions

Large-scale studies examining the impact of whole food diets versus ultra-processed foods on metabolic health, inflammation markers, and chronic disease progression.

Digital Health Analytics

AI-driven analysis of wearable device data to predict health outcomes and optimize personalized intervention strategies.

Environmental Health

Investigating the relationship between environmental toxins, food contamination, and the rising incidence of chronic diseases and developmental disorders.

Integrative Medicine

Clinical trials combining conventional medical treatments with evidence-based complementary therapies for optimal patient outcomes.

Key Research

  • Johns Hopkins University: Collaborative studies on nutrition's role in chronic disease prevention
  • Stanford Medicine: AI-powered predictive health analytics research
  • Harvard T.H. Chan School of Public Health: Population-level dietary intervention studies
  • Mayo Clinic: Integrative medicine clinical trials
  • National Institutes of Health (NIH): Government-funded research initiatives
  • CDC Foundation: Public health data analysis and intervention studies

Current Studies

The MAHA Nutrition Trial (2025-2027)

A 10,000-participant randomized controlled trial examining the effects of eliminating ultra-processed foods and implementing whole-food diets on biomarkers of chronic disease. Primary endpoints include HbA1c levels, inflammatory markers, and cardiovascular risk factors.

Digital Health Prediction Study (2024-2026)

Longitudinal analysis of wearable device data from 50,000 users to develop AI models predicting diabetes, cardiovascular events, and metabolic dysfunction before clinical symptoms appear.

Environmental Toxin Impact Assessment (2025-2028)

Multi-site study investigating the correlation between environmental toxin exposure and childhood developmental disorders, supporting MAHA's environmental health initiatives.